{"disease":{"id":"benign-pigmented-lesions","name":"benign pigmented lesions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03774849","title":"PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles","phase":"NA","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Candela Corporation","has_results":true},{"nct_id":"NCT05096247","title":"Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Cynosure, Inc.","has_results":true},{"nct_id":"NCT04208100","title":"Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":41,"lead_sponsor_name":"CynosureLutronic","has_results":false},{"nct_id":"NCT05102617","title":"Post Market Usability Evaluation Of The PicoSure Pro Device","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Cynosure, Inc.","has_results":false},{"nct_id":"NCT04807205","title":"Post Market Study Using The Elite IQ Device","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Cynosure, Inc.","has_results":true},{"nct_id":"NCT03409952","title":"Lutronic LaseMD for Treatment of Benign Pigmented Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"CynosureLutronic","has_results":false},{"nct_id":"NCT04861246","title":"Evaluation of Laser Treatment for Benign Pigmented Lesions by Non-invasive, Cellular Resolution Optical Coherence Tomography","phase":"NA","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}